Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026)
Quarterly Total Liabilities rose 22.68% to $24.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Mar 2026, up 22.68% year-over-year, with the annual reading at $23.4 million for FY2025, 14.82% up from the prior year.
Tyra Biosciences filings provide 7 years of Total Liabilities readings, the most recent being $24.5 million for Q1 2026.
- Total Liabilities hit $24.5 million in Q1 2026 for Tyra Biosciences, up from $23.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $24.5 million in Q1 2026 and bottomed at $6.3 million in Q1 2023.
- Average Total Liabilities over 5 years is $15.7 million, with a median of $16.4 million recorded in 2024.
- The largest annual shift saw Total Liabilities plummeted 63.54% in 2022 before it skyrocketed 158.56% in 2023.
- Tyra Biosciences' Total Liabilities stood at $8.4 million in 2022, then soared by 158.56% to $21.6 million in 2023, then fell by 5.5% to $20.4 million in 2024, then increased by 14.82% to $23.4 million in 2025, then rose by 4.41% to $24.5 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Total Liabilities are $24.5 million (Q1 2026), $23.4 million (Q4 2025), and $21.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 9.45 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 10.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 24.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.47 Mn |
| Dec 31, 2025 | 23.43 Mn |
| Sep 30, 2025 | 21.34 Mn |
| Jun 30, 2025 | 19.35 Mn |
| Mar 31, 2025 | 19.94 Mn |
| Dec 31, 2024 | 20.41 Mn |
| Sep 30, 2024 | 18.30 Mn |
| Jun 30, 2024 | 16.42 Mn |
| Mar 31, 2024 | 14.86 Mn |
| Dec 31, 2023 | 21.60 Mn |
| Sep 30, 2023 | 16.19 Mn |
| Jun 30, 2023 | 11.44 Mn |
| Mar 31, 2023 | 6.27 Mn |
| Dec 31, 2022 | 8.35 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 7.79 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 6.24 Mn |
| Jun 30, 2021 | 22.67 Mn |
| Mar 31, 2021 | 17.52 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 10.08 Mn |